Clinical trials
Enrolling by invitation Endometrial Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogenea Pharmaceuticals Ltd. | 1 |
| Rocky Vista University, LLC | 1 |
| Rutgers, The State University of New Jersey | 1 |
| Tampere University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 4 |
| Adenocarcinoma | 1 |
| Diabetes Mellitus | 1 |
| Hypercholesterolemia | 1 |
| Hyperlipidemias | 1 |
| Hypertension | 1 |
| Neoplasms | 1 |
| Prostatic Neoplasms | 1 |
| Urinary Bladder Neoplasms | 1 |
| Uterine Cervical Neoplasms | 1 |
Trials
Showing 51 to 4 of 4. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.